Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227632 is a human pseudogene annotated as similar to part of CDC42 binding protein kinase beta (CDC42BPB), also referred to as DMPK-like. Pseudogenes are segments of DNA that resemble known genes but lack functional protein expression either due to mutations or truncation. They typically do not encode active proteins and are generally considered non-functional, lacking roles in biological processes, disease, drug interactions, or use as biomarkers. The corresponding protein-coding gene, CDC42BPB, encodes a serine/threonine-protein kinase that regulates actin cytoskeleton organization and cell migration, but ENSG00000227632 does not share these functions. Key point: ENSG00000227632 is a pseudogene, not a therapeutic target, and should not be considered for drug targeting or biomarker development. For information about functional protein activity, refer to the actual CDC42BPB gene, not this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of CDC42 binding protein kinase beta.